Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in
IDEA Collider: Innovation & Asymmetric Learning in Pharma artwork

Podcast

IDEA Collider: Innovation & Asymmetric Learning in Pharma

IDEA Pharma, SAI MedPartners

Science · 74 episodes
  • Website
Follow

Guests who follow get this show's guest call alerts.

Subscribe+ Add a credit

IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. The podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.Questions We Explore* What is asymmetric learning, and how does it fuel pharma innovation?* Why do some organizations outpace others - and...

Listen on
  • Apple Podcasts
  • Find on Spotify
EpisodesPeoplePostsSubscribe

Is this your show? Claim this page

Information

Creator
IDEA Pharma, SAI MedPartners
Category
Science
Years active
2019 to 2026
Episodes
74
Copyright
2026 IDEA Collider
Show website
ideacollider.simplecast.com

Sign in to suggest a network

PodCred

The people behind this show

People get invited back because someone remembered they were great.

PodCred is the verified record of who made this show. A credit here means people who were there confirmed the work.

Hosts

  • I
    IDEA PharmaHostFeed-stated

Who is on this show?

Think of the guest you still think about. The producer who makes the host sound smart. The editor who saves every episode. If a name is missing here, that person is invisible everywhere.

Add a credit

Episodes

74 episodes
74 episodes
  1. ESMO 2026 Preview: Key studies that could fundamentally change the oncology landscape.

    Oct 22, 202642 minAudio

    In this episode of the IDEA Collider podcast, Alex Gray, Chief Medical Officer at SAI & IDEA Pharma, John Barry, Executive Vice President at SAI, and Tom Brockbank, Senior Consultant at IDEA Pharma, look ahead to ESMO...

    Credit the people on this episode

  2. AI-Driven Pharma Market Research: Synthetic Users - with Kwame Ferreira & Rebecca Gould.

    Oct 7, 202641 minAudio

    Welcome back to the IDEA Collider podcast. In this episode, host Rick Ritacco sits down with Kwame Ferreira, Founder of Synthetic Users, and Rebecca Gould, President, Strategic Consulting & Analytics Business Unit at...

    Credit the people on this episode

  3. The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO Revolution: Part II

    Sep 14, 202636 minAudio

    Welcome back to the IDEA Collider podcast. In this second instalment of our future of immuno-oncology series, Alex Gray is joined by colleagues David Radwaner and Tom Brockbank to discuss what lies ahead for cancer...

    Credit the people on this episode

  4. Targeting the Totality of MS: Jason Tardio on Immunic’s Combined Neuroprotective and Anti-Inflammatory Strategy

    Jul 16, 202649 minAudio

    Welcome to IDEA Collider with your host, Rick Ritacco. In this episode, we sit down with Jason Tardio, President and COO of Immunic, to discuss the rapidly evolving landscape of Multiple Sclerosis (MS) treatment. For 30...

    Credit the people on this episode

  5. The Future of Psychedelic Medicine: Clinical Strategy and Scaling Access.

    Jul 1, 202650 minAudio

    Welcome to a special edition of IDEA Collider’s "Deep Medicine" series. In this episode, host Alex Gray sits down with Athina Metaxa, a consultant at IDEA Pharma and psychedelic research expert, to discuss the rapidly...

    Credit the people on this episode

  6. The Power of the Early Narrative: Sue Wood on Strategic Biotech Positioning

    Jun 24, 202643 minAudio

    Welcome to IDEA Collider with your host, Rick Ritacco. In this episode, we sit down with Sue Wood, a senior expert at IDEA Pharma with a PhD from Oxford and decades of experience translating complex scientific concepts...

    Credit the people on this episode

  7. The Execution Problem: Alex Gray and Jacqueline Poot on Pharma Decision Intelligence.

    Jun 12, 20261 hr 3 minAudio

    Welcome to IDEA Collider. In this episode, host Dr. Alex Gray, Chief Medical and Innovation Officer at IDEA Pharma, is joined by colleague Jacqueline Poot, President of Strategic Consulting and Analytics, to discuss the...

    Credit the people on this episode

  8. The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO Revolution

    May 28, 202621 minAudio

    Welcome to IDEA Collider. In this episode, host Alex Gray is joined by IDEA Pharma colleagues David Radwaner and Tom Brockbank to dissect the history, strategy, and future of immuno-oncology (IO). The trio explores how...

    Credit the people on this episode

  9. Scaling TCR-T Therapies: Reagan Jarvis on Non-Viral Gene Editing and Target Mapping

    May 13, 202635 minAudio

    In this episode of the IDEA Collider, host Mike Rea sits down with Reagan Jarvis, scientific founder and CEO of Anocca, to explore how TCR-T cell therapy could unlock the next frontier in cancer treatment - particularly...

    Credit the people on this episode

  10. Vir Biotechnology: Marianne De Backer on Immuno-Oncology, Hepatitis Delta, and Biotech Turnarounds

    Apr 27, 202636 minAudio

    In this episode of the IDEA Collider, host Mike Rea sits down with Marianne De Backer, CEO of Vir Biotechnology, to explore how she is leading one of biotech’s most complex transformations. After the rapid rise and...

    Credit the people on this episode

  11. Building the Future of Targeted Protein Degradation Medicines with Nello Mainolfi

    Mar 11, 202641 minAudio

    In this episode of IDEA Collider, host Mike Rea sits down with Nello Mainolfi, founder and CEO of Kymera Therapeutics. Nello shares his journey from medicinal chemist to biotech founder and discusses the opportunities...

    Credit the people on this episode

  12. AI & Competitive Intelligence in Pharma: Smarter Decision-Making with SAI MedPartners

    Feb 26, 202653 minAudio

    In this episode of the IDEA Collider podcast, industry experts explore the evolving role of AI in Competitive Intelligence (CI) in pharmaceutical and biotech strategy - and how organizations can move beyond data...

    Credit the people on this episode

  13. Rewriting the Future of Rare Disease: Engineered tRNA and a New Therapeutic Paradigm with Michelle Werner

    Feb 18, 202641 minAudio

    In this episode of IDEA Collider, host Mike Rea sits down with Michelle Werner, CEO of Alltrna, to explore a groundbreaking approach that could transform how we treat thousands of genetic diseases. Michelle shares how...

    Credit the people on this episode

  14. Revitalizing Pharma Collaborations: The Reblozyl Case Study

    Dec 22, 202544 minAudio

    In this episode of IDEA Collider, hosts Mike and Rick revisit a pivotal project from over a decade ago, the Reblozyl project, undertaken in collaboration with Acceleron and Celgene. Rick, the head of Growth and...

    Credit the people on this episode

  15. Pioneering the Future of Cardiovascular Treatment with Sekar Kathiresan

    Dec 8, 202551 minAudio

    In this episode of IDEA Collider, host Mike Rea speaks with Dr. Sekar Kathiresan, founder of Verve Therapeutics and now part of Eli Lilly, about one of the boldest ideas in modern medicine: using one-time gene editing...

    Credit the people on this episode

Show moreShowing 15 of 74

Posts

No posts yet. Posts IDEA Collider: Innovation & Asymmetric Learning in Pharma shares on PodSubs, and what it publishes on Substack, YouTube and its own site, will show here.

Be the first to rate this show

Subscribe

Be on the front line of the show

Everything IDEA Collider: Innovation & Asymmetric Learning in Pharma sends its own people, first. Resources, announcements, behind the scenes, events, and giveaways, straight from the host. No account needed.

  • The resources the host shares with subscribers
  • Announcements before anyone else hears
  • Behind the scenes from the team
  • Events, invitations, and giveaways
  • Only what the host sends, nothing else
How often

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Report this show

Similar shows

  • Huberman Lab artwork

    Huberman Lab

    Also in Science

    294 episodes

    Updated Nov 21, 2026

  • Stuff To Blow Your Mind artwork

    Stuff To Blow Your Mind

    Also in Science

    3,259 episodes

    Updated Nov 21, 2026

  • Something You Should Know artwork

    Something You Should Know

    Also in Science

    1,372 episodes

    Updated Nov 21, 2026

  • Meteor artwork

    Meteor

    Also in Science

    65 episodes

    Updated Nov 21, 2026

  • Bigfoot Eyewitness Radio artwork

    Bigfoot Eyewitness Radio

    Also in Science

    569 episodes

    Updated Nov 21, 2026

  • Authentic Biochemistry artwork

    Authentic Biochemistry

    Also in Science

    1,362 episodes

    Updated Nov 21, 2026

  • Health Lab artwork

    Health Lab

    Also in Science

    543 episodes

    Updated Nov 20, 2026

  • The Science Show artwork

    The Science Show

    Also in Science

    252 episodes

    Updated Nov 20, 2026